Athenex to Host Conference Call with Key Opinion Leader Following Oral Presentation of Phase III Results of KX2-391 Ointment in the Treatment of Actinic Keratosis at the American Academy of Dermatology Annual Meeting

    NEXT STORY
    Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD
    PREV STORY
    Batavia Biosciences Receives $13.2M Grant to Accelerate Market Access of Low-Cost Inactivated Polio Vaccine
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ORYZON receives approval to start ALICE: a Phase IIa clinical trial in AML with Iadademstat (ORY-1001)

    The study will be done in elderly Acute Myeloid Leukemia (AML) patients not eligible ...

    author_avatar
    NASDAQ Market News

    Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin™ Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial

    SHANGHAI, China and CUPERTINO, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group ...

    author_avatar
    NASDAQ Market News

    Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

    Abeona’s Third Gene Therapy Program to Receive FDA Orphan Designation EB-101 Gene Therapy for ...

    author_avatar
    NASDAQ Market News